Rodriguez Susan

Rodriguez Susan is listed in filings as CCSO at Monopar Therapeutics Inc.. This profile follows SEC Form 4 activity through Mar 4, 2026, including 8 public disclosures. Recent filings connect the profile to Monopar Therapeutics Inc. (MNPR), Avadel Pharmaceuticals plc (AVDL), Veradigm Inc. (MDRX), and Heron Therapeutics, Inc. (HRTX). The current snapshot covers public activity from Feb 3, 2025 to Mar 4, 2026. Reported amounts are shown as $2.6M to $200.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.